Table 1.
Baseline characteristics of the included studies (FD/SAC).
| Study (year) | Country | Enrollment Period | n Patients | n Aneurysms | R | Mean age (SD) [range] | F | VA | BA | VBA | VA-PICA | PCA | ICA | Follow-up time (SD) [range] mo |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Catapano et al. (2021) 13 | USA | January 1, 1999– December 31, 2019 | 29/15 | 29/15 | 7/8 | NA | NA | 24/13 | 0 | 1/2 | 4/0 | 0 | 0 | NA |
| Cho et al. (2019) 14 | South Korea | January 2009–December 2017 | 7/9 | 7/9 | 0/0 | 47.6 (22.1) / 54.3 (14.7) | 5/6 | 5/9 | 2/0 | 0 | 0 | 0 | 0 | 16.3 (13.1) / 27 (23.4) |
| Kaschner et al. (2019) 15 | Germany | January 2004–July 2018 | 8/4 | 9/4 | 7/4 | 46.625 / 48.25 | 2/1 | 5/4 | 1/0 | 1/0 | 0 | 1/0 | 1/0 | 9.66 / 2.98 |
| Li et al. (2020) 16 | China | January 2010–September 2018 | 4/10 | 4/10 | 0/0 | 31.5 / 54.1 | 2/0 | 3/10 | 0 | 1/0 | 0 | 0 | 0 | 12.5 / 14.5 |
| Schob et al. (2019) 17 | Germany | January 2010–May 2018 | 3/4 | 3/4 | 3/4 | 59.33 / 58.25 | 3/2 | 3/4 | 0 | 0 | 0 | 0 | 0 | 4 / 17.75 |
| Zhang et al. (2020) 18 | China | January 2009–December 2018 | 8/15 | 12/21 | 0/2 | NA | NA | 2/17 | 0 | 0 | 10/4 | 0 | 0 | 6.375 / 13 |
| Duangprasert et al. (2023) 19 | Thailand | March 2015–May 2022 | 11/3 | 11/3 | 11/3 | NA | NA | 9/3 | 0 | 0 | 2/0 | 0 | 0 | NA |
| Han et al. (2023) 5 | China | January 2016–December 2020 | 65/59 | 65/59 | 0/0 | 53 [47–58] / 53 [48–61] | 11/11 | 49/46 | 0 | 2/3 | 14/10 | 0 | 0 | 11 [6–28] / 10 [6–30] |
| Oh et al. (2023) 3 | Korea | April 2009–September 2021 | 24/48 | 24/48 | 0/0 | 54.7 (10.9) / 57.6 (10.7) | 12/28 | 17/41 | 0 | 0 | 7/7 | 0 | 0 | 13.5 [6–60] / 32.13 [6–120] |
| Wu et al. (2023) 20 | China | January 2014–March 2022 | 36/55 | 38/57 | 0/0 | 55.1 (8.9) / 58.3 (9.6) | 9/18 | 24/46 | 0 | 14/11 | 0 | 0 | 0 | 7 [6–10] / 9 [6–14] |
NA: not available; SD: standard deviation; n: number; F: female; R: ruptured; Ret: retrospective; mo: months.